Lv1
30 积分 2026-01-22 加入
[Consensus on diagnosis and treatment of complement-mediated kidney diseases]
1个月前
已完结
Pharmacokinetics, Safety, and Tolerability of Anti-miR-17 Oligonucleotide RGLS4326 in Healthy Adult Subjects
1个月前
已完结
Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: A role for combination fibrate therapy
2个月前
已完结
Apolipoprotein C-III Inhibition — Killing Two Birds with One Stone?
2个月前
已完结
An Adolescent Boy with Nutcracker-Syndrome and IgA Nephropathy
2个月前
已完结
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
2个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
3个月前
已完结
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial
3个月前
已完结
Natural history and predictors of survival in progressive supranuclear palsy
4个月前
已完结
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
4个月前
已完结
皖公网安备34019202002308
